DOI: https://dx.doi.org/10.18565/urology.2023.6.145-150
Kamalov A.A., Sorokin N.I., Kadrev A.V., Shaparov B.M., Afanasevskaya E.V., Sindeeva O.A., Sukhorukov G.B., Kritsky A.A., Pyataev N.A., Abdurashitov A.S., Kulikov O.A., Proshin P.I.
1) Urology and Andrology Branch, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia; 2) Department of Urology and Andrology, Lomonosov MSU Medical Research and Educational Center, Moscow, Russia; 3) A.V. Zelmann Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, Moscow, Russia; 4) LLC Magnetic Drug Delivery, AMT & C Group, Moscow, Russia; 5) Institute of Medicine, National Research Ogarev Mordovia State University, Saransk, Russia; 6Moscow City Clinical Hospital No. 17, Moscow, Russia; 7Istra Regional Clinical Hospital, Istra, Russia
Corresponding author: B.M. Shaparov – urologist at the Urologic Department of the GBUZ City Clinical Hospital No. 17 of Moscow Healthcare Department, Moscow, Russia; e-mail: uroboris@mail.ru